LEITAT Technological Center. Biomed Division
Contact details
Carrer Baldiri Reixac, 15-21 Edifici Hèlix, Parc Científic de Barcelona
08028 Barcelona (Barcelona)
Espanya
Telephone: +34 934 020 417
Fax: +34 934 037 035
biomed@leitat.org
Visit Website
Contact person
Francesc Mitjans Prat, Division Manager | fmitjans@leitat.org
General information
Type of organization: Company
Founding year: 1906
Business model and activity description
Description
Leitat Technological Center is a private non-profit research Center and our main commitment is to give technological support to enterprises and institutions.
Main activities
- >> Manufacturing
- >> R&D
- >> Sales & Marketing
- >> Services & Related
Main areas
- >> Biotechnology
- >> Human Health: Pharmacological or Biological Therapeutics
- >> Contract Research Organisation (private entity) / Outsourced R&D (for research groups and public entities)
- >> 24
R&D lines
The Biomed Division is the new unit of LEITAT, that identifies new targets for oncology research, and searches innovative drugs for cancer treatment. This unit is also in charge of the coordination for the global technological offer directed to the bio and med sectors.
R&D lines include the identification of new targets for oncology and the generation of NME (New Molecular Entities) to modulate them and eventually fully characterize its in vitro & in vivo profiles in order to deliver these innovative drugs ready for clinical phases.
The Biotech Division is mainly focused in enzymes application for the substitution of the less efficient and environmentally unfriendly chemical processes with biotechnological ones. Enzymes application in industrial processes, in wastewater treatment and applied in the substitution of chemical processes.
Enzyme immobilization.
Antibacterial, antifungal, antimite, … materials, finishes and processes.
Microencapsulation of active products.
Sterilization processes.
Biodegradable, biocompatible materials and plastics.
Development of new polymers based on biomass monomers, new polymers charges with natural compound. Study and increase of the recyclability of polymers.
Development of medical devices, prosthesis and implants, aids for plastic surgery, tissue engineering, crane and maxilo-facial surgery, dental implants, guides, surgical templates and instruments
End users
- >> Patient: Implants
Differential features of the technology used, main facilities and/or instrumentations available
In Vitro & In Vivo Oncologic Models, Generation of Monoclonal Antibodies
Results and development
Services and products
Preclinical Services:
A broad battery of oncologic in vitro & in vivo models to the pharmaceutical industries and others. We also provide the basis to identify unrevealed indications for known leads.
Custom mAb.
Custom Mab according to client needs. Immu
Last updated
04/05/2012